Our COVID19 phase 2 clinical trial for our lead product, rhu-pGSN, has begun.

Share on facebook
Share on twitter
Share on linkedin

October 6-7, 2020: BioNJ’s 10th Annual BioPartnering Conference

Virtual Conference:

Navigating Unprecedented Global Uncertainty

Tuesday, October 6th and Wednesday, October 7th 2020


Developed with J.P. Morgan and Johnson & Johnson InnovationBioNJ’s Virtual Two-Day BioPartnering Conference will bring together life sciences professionals from the Northeast and beyond. Last year’s Conference convened attendees representing 17 states and 5 countries. Come ready to meet investors, industry executives and partnering professionals; pre-schedule 1:1 partnering meetings; talk to exhibitors; attend plenary sessions and build your professional network! Plus…


Company Presentations from Emerging Life Sciences Organizations
October 6th 1:30pm – 3:00pm
Ariel Precision MedicineImmunic TherapeuticsRenovaCare, Inc.
9 Meters Biopharma, Inc.Insmed IncorporatedRTsafe
Aclipse TherapeuticsIntrommune TherapeuticsSCYNEXIS
Adastra Pharmaceuticals Inc.Jubilant TherapeuticsSimphotek
AustarPharma, LLCKayotheraStemBioSys, Inc.
Azure Biotech, Inc.Levolta PharmaceuticalsSynthis
BioAegis Therapeutics, Inc.Neumentum, Inc.Tactical Therapeutics, Inc.
Blaze Bioscience, Inc.OcuMedic, Inc.Third Pole Therapeutics
Chromocell CorporationOncoceuticsTyme, Inc.
Evrys BioOncoSec Medical IncorporatedViamer Biosciences
FLUIDDA Inc.PhageNova Bio, Inc.Virion Therapeutics
Geistlich PharmaProvid Pharmaceuticals, Inc.Visikol, Inc.
Immune Regulation Ltd.QlibriumWellsheet, Inc.